Breast reduction surgery and breast cancer risk: Does reduction mammaplasty have a role in primary prevention strategies for women at high risk of breast cancer?

Plastic and Reconstructive Surgery

Volumn 113, Issue 7, 2004, Pages 2104-2110

  Tarone, Robert E ^b   Lipworth, Loren ^b   Young, V Leroy ^b   McLaughlin, Joseph K ^a  

^a INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST REDUCTION; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CONFIDENCE INTERVAL; EVALUATION; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MASTECTOMY; OUTCOMES RESEARCH; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; TREATMENT INDICATION; BREAST RECONSTRUCTION; BREAST TUMOR; FEMALE; GENETIC PREDISPOSITION; GENETICS; RISK FACTOR;

BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAMMAPLASTY; PRIMARY PREVENTION; RISK FACTORS;

EID: 4444347651     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000122407.07002.95     Document Type: Review

References (56)

1. Blanchard, D. K., and Hartmann, L. C. Prophylactic surgery for women at high risk for breast cancer. Clin. Breast Cancer 1: 127, 2000.
2. Stefanek, M., Hartmann, L., and Nelson, W. Risk-reduction mastectomy: Clinical issues and research needs. J. Natl. Cancer Inst. 93: 1297, 2001.
3. Meijers-Heijboer, H., van Geel, B., van Putten, W. L. J., et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N. Engl. J. Med. 345: 159, 2001.
4. Kennedy, R. D., Quinn, J. E., Johnston, P. G., and Harkin, D. P. BRCA1: Mechanisms of inactivation and implications for management of patients. Lancet 360: 1007, 2002.
5. van Roosmalen, M. S., Verhoef, L. C. G., Stalmeier, P. F. M., Hoogerbrugge, N., and van Daal, W. A. J. Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: A more prominent role for oophorectomy. J. Clin. Oncol. 20: 2092, 2002.
6. Roukos, D. H., Agnanti, N. J., Paraskevaidis, E., and Kappas, A. M. Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers of BRCA1 or BRCA2 mutations. Ann. Surg. Oncol. 9: 941, 2002.
7. Powles, T. J. Anti-oestrogenic prevention of breast cancer: The make or break point. Nat. Rev. Cancer 2: 787, 2002.
8. Hartmann, L. C., Schaid, D. J., Woods, J. E., et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N. Engl. J. Med. 340: 77, 1999.
9. Hartmann, L. C., Sellers, T. A., Schaid, D. J., et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J. Natl. Cancer Inst. 93: 1633, 2001.
10. McDonnell, S. K., Schaid, D. J., Myers, J. L., et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J. Clin. Oncol. 19: 3938, 2001.
11. Lynch, H. T., Lemon, S. J., Durham, C., et al. A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer 79: 2219, 1997.
12. Frost, M. H., Schaid, D. J., Sellers, T. A., et al. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. J.A.M.A. 284: 319, 2000.
13. Lerman, C., Hughes, C., Croyle, R. R., et al. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev. Med. 31: 75, 2000.
14. Meijers-Heijboer, E. J., Verhoog, L. C., Brekelmans, C. T. M., et al. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 355; 2015, 2000.
15. Julian-Reynier, C. M., Bouchard, L. J., Evans, D. G., et al. Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: Differences among English, French, and Canadian women. Cancer 92: 959, 2001.
16. Evans, D. G. R., Lalloo, F., Shenton, A., Boggis, C., and Howell, A. Uptake of screening and prevention in women at very high risk of breast cancer. Lancet 358: 889, 2001.
17. Botkin, J. R., Smith, K. R., Croyle, R. T., et al. Genetic testing for a BRCA1 mutation: Prophylactic surgery and screening behavior in women 2 years post testing. Am. J. Med. Genet. 118A: 201, 2003.
18. Meijers-Heijboer, H., Brekelmans, C. T. M., Menke-Pluymers, M., et al. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. J. Clin. Oncol. 21: 1675, 2003.
19. Eisen, A., and Weber, B. L. Prophylactic mastectomy: The price of fear. N. Engl. J. Med. 340: 137, 1999.
20. Swanson, G. P. Re: Risk reduction mastectomy: Clinical issues and research needs (Letter). J. Natl. Cancer Inst. 94: 143, 2002.
21. Stefanek, M., Hartmann, L., and Nelson, W. Re: Risk reduction mastectomy: Clinical issues and research needs (Reply). J. Natl. Cancer Inst. 94: 143, 2002.
22. Lund, K., Ewertz, M., and Schou, G. Breast cancer incidence subsequent to surgical reduction of the female breast. Scand. J. Plast. Reconstr. Hand Surg. 21: 209, 1987.
23. Baasch, M., Nielsen, S. F., Engholm, G., and Lund, K. Breast cancer incidence subsequent to surgical reduction of the female breast. Br. J. Cancer 73: 961, 1996.
24. Brinton, L., Malone, K. E., Coates, R. J., et al. Breast enlargement and reduction: Results from a breast cancer case-control study. Plast. Reconstr. Surg. 97: 269, 1996.
25. Boice, J. D., Friis, S., McLaughlin, J. K., et al. Cancer following breast reduction surgery in Denmark. Cancer Causes Control 8: 253, 1997.
26. Brown, M. H., Weinberg, M., Chong, N., Levine, R., and Holowaty, E. A cohort study of breast cancer risk in breast reduction patients. Plast. Reconstr. Surg. 103: 1674, 1999.
27. Boice, J. D., Persson, I., Brinton, L., et al. Breast cancer following breast reduction surgery in Sweden. Plast. Reconstr. Surg. 106: 755, 2000.
28. Brinton, L. A., Persson, I., Boice, J. D., McLaughlin, J. K., and Fraumeni, J. F., Jr. Breast cancer risk in relation to amount of tissue removed during breast reduction operations in Sweden. Cancer 91: 478, 2001.
29. Eisen, A., Rebbeck, T. R., Wood, W. C., and Weber, B. L. Prophylactic surgery in women with hereditary predisposition to breast and ovarian cancer. J. Clin. Oncol. 18: 1980, 2000.
30. Narod, S. Prophylactic mastectomy in carriers of BRCA mutations (Letter). N. Engl. J. Med. 345: 1498, 2001.
31. Klaren, H. M., van't Veer, L. J., van Leuwen, F. E., and Rookus, M. A. Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation. J. Natl. Cancer Inst. 95: 941, 2003.
32. Franceschi, S. Breast size, breast reduction, and cancer risk. Cancer Causes Control 8: 125, 1997.
33. Zhuang, S. H., Leonard, G. D., and Swain, S. M. Oophorectomy in carriers of BRCA mutations (Letter), N. Engl. J. Med. 347: 1037, 2002.
34. Whitfield, G. A. Oophorectomy in carriers of BRCA mutations (Letter). N. Engl. J. Med. 347: 1039, 2002.
35. Snyderman, R. K., and Lizardo, J. G. Statistical study of malignancies found before, during, or after routine breast plastic operations. Plast. Reconstr. Surg. 25: 253, 1960.
36. Jansen, D. A., Murphy, M., Kind, G. M., and Sands, K. Breast cancer in reduction mammoplasty: Case reports and a survey of plastic surgeons. Plast. Reconstr. Surg. 101: 361, 1998.
37. White, R. R. Incidence of breast carcinoma in patients having reduction mammaplasty (Letter). Plast. Reconstr. Surg. 102: 1774, 1998.
38. Tang, C. L., Brown, M. H., Levine, R., Sloan, M., Chong, N., and Holowaty, E. Breast cancer found at the time of breast reduction. Plast. Reconstr. Surg. 103: 1682, 1999.
39. Egan, K. M., Newcomb, P. A., Titus-Ernstoff, L., et al. The relation of breast size to breast cancer risk in postmenopausal women (United States). Cancer Causes Control 10: 115, 1999.
40. Tavani, A., Pregnolato, A., La Vecchia, C., Negri, E., Favero, A., and Franceschi, S. Breast size and breast cancer risk. Eur. J. Cancer Prev. 5: 337, 1996.
41. Thurfjell, E., Hsieh, C. C., Lipworth, L., Ekbom, A., Adami, H. O., and Trichopoulos, D. Breast size and mammographic pattern in relation to breast cancer risk. Eur. J. Cancer Prev. 5: 37, 1996.
42. Boyd, N. F., Lockwood, G. A., Byng, J. W., Tritchler, D. L., and Yaffe, M. J. Mammographic densities and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 7: 1133, 1998.
43. Vachon, C. M., Kuni, C. C., Anderson, K., Anderson, V. E., and Sellers, T. A. Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control 11: 653, 2000.
44. Page, D. L., Schuyler, P. A., Dupont, W. D., Jensen, R. A., Plummer, W. D., and Simpson, J. F. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: A retrospective cohort study. Lancet 361: 125, 2003.
45. Karabela-Bouropoulou, V., Liapi-Avgeri, G., Iliopoulou, E., and Agnantis, N. J. Histological findings in breast tissue specimens from reduction mammoplasties. Pathol. Res. Pract. 190: 792, 1994.
46. Butler, C. E., Hunt, K. K., and Singletary, S. E. Management of breast carcinoma identified during reduction mammoplasty. Ann. Plast. Surg. 50: 193, 2003.
47. American Society of Plastic Surgeons. Cosmetic surgery trends: Reconstructive surgery trends. Arlington, Ill.: American Society of Plastic Surgeons. Available at: http://www.plasticsurgery.org/find_plastic_surgery/ dermabrasion-light.html.
48. Wells, S. A., Jr., Young, V. L., and Andriole, D. A. Atlas of Breast Surgery. St. Louis, Mo.: Mosby, 1994. Pp. 295-320.
49. Chadbourne, E. B., Zhang, S., Gordon, M. J., et al. Clinical outcomes in reduction mammaplasty: A systematic review and meta-analysis of published studies. Mayo Clin. Proc. 76: 503, 2001.
50. Russo, J., Lynch, H., and Russo, I. H. Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast J. 7: 278, 2001.
51. Speirs, V., Skliris, G. P., Burdall, S. E., and Carder, P. J. Distinct expression patterns of ER alpha and ER beta in normal human mammary gland. J. Clin. Pathol. 55: 371, 2002.
52. Gabriel, S. E., Woods, J. E., O'Fallon, W. M., Beard, C. M., Kurland, L. T., and Melton, L. J. Complications leading to surgery after breast implantation. N. Engl. J. Med. 336: 677, 1997.
53. Hang-Fu, L. Subjective comparison of six different reduction mammoplasty procedures. Aesthetic Plast. Surg. 15: 297, 1991.
54. Velanovich, V. Should general surgeons perform specialty procedures? An outcome experience with reduction mammoplasty. Am. Surg. 62: 156, 1996.
55. Harbo, S. O., Jørum, E., and Roald, H. E. Reduction mammaplasty: A prospective study of symptom relief and alterations of skin sensibility. Plast. Reconstr. Surg. 111: 103, 2003.
56. Johansson, Å. S., Wennborg, H., Blomqvist, L., Isacson, D., and Kylberg, E. Breastfeeding after reduction mammaplasty and augmentation mammaplasty (Letter). Epidemiology 14: 127, 2003.